Zdrowie i gospodarka · 21/12/1994

Pediatric Dosing with Over-the-Counter Drug Products; Summary Information Document for Advisory Committee Meeting; Availability; Establishment of a Public Docket and Request for Comments

The Food and Drug Administration (FDA) is announcing the availability of a summary information document for the Nonprescription Drugs Advisory Committee meeting on pediatric dosing with over-the- counter (OTC) drug products. Elsewhere in this issue of the Federal Register, the agency is announcing a forthcoming meeting of this advisory committee. The action is being taken to ensure that all interested parties are aware of the issues that are the subject of the committee discussion. FDA is also announcing that it has established a public docket for comments, views, and other information submitted to the agency on these subjects from interested persons.